![](/img/cover-not-exists.png)
A phase II trial evaluating two schedules of sagopilone (ZK-EPO), a novel epothilone, in patients with platinum-resistant ovarian cancer
Rustin, G., Reed, N., Jayson, G. C., Ledermann, J. A., Adams, M., Perren, T., Poole, C., Lind, M., Persic, M., Essapen, S., Gore, M., Calvert, H., Stredder, C., Wagner, A., Giurescu, M., Kaye, S.Volume:
22
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdq780
Date:
November, 2011
File:
PDF, 115 KB
english, 2011